Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Olivier Rascol92
Dopamine Agonists (adverse effects)8
Olivier Rascol Sauf Dopamine Agonists (adverse effects)" 87
Dopamine Agonists (adverse effects) Sauf Olivier Rascol" 3
Olivier Rascol Et Dopamine Agonists (adverse effects) 5
Olivier Rascol Ou Dopamine Agonists (adverse effects) 95
Corpus679
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000223 Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database
000429 Olivier Rascol [France] ; Atul Pathak [France] ; Haleh Bagheri [France] ; Jean-Louis Montastruc [France]New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance
000435 Olivier Rascol [France] ; Atul Pathak [France] ; Haleh Bagheri [France] ; Jean-Louis Montastruc [France]Dopaminagonists and fibrotic valvular heart disease: Further considerations
000506 Jean-Louis Montastruc [France] ; Olivier Rascol [France]Modafinil and pramipexole‐associated somnolence
000560 Korczyn [Israël] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Warner H. Poewe [Autriche] ; Olivier Rascol [France] ; Fabrizzio Stocchi [Italie]Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024